Statin, Beyond Hyperlipidemia toward a Novel Agent for Hepatitis C & Authors' Reply

CITEDBY Reports

  1. Qianqian Zhu, Qunying Han, Zhengwen Liu, . Potential role for statins in the treatment of chronic HCV infection. Future Virology, 2013; 8(8): 727.
    Crossref
  2. Yi-Xiang Zheng, Peng-Cheng Zhou, Rong-Rong Zhou, Xue-Gong Fan, . The benefit of statins in chronic hepatitis C patients. European Journal of Gastroenterology & Hepatology, 2017; 29(7): 759.
    Crossref
  3. Michael S. Kostapanos, Christos V. Rizos, Moses S. Elisaf, . Benefit–Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related Diseases. Drug Safety, 2014; 37(7): 481.
    Crossref